Vanessa Valarezo, MD
Obstetrics & Gynecology · Parsippany, NJNPI 1891239034
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,250 of the $8,970 with a category attached, or 92.0%. Celularity Inc. accounts for 92.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $3,865 and has fallen 98.9% since, to $41 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $119.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$8K
- Therapeuticsmd, Inc.$111
- AbbVie$100
- Bayer$82
- Exact Sciences$46
- Mayne Pharma Commercial LLC$41
- plus $284 from 13 others
What the payments were for
- Speaking & faculty fees$8,25092%
- Food & beverage$6858%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 31 | $8,306 |
| Therapeuticsmd, Inc. | 8 | $111 |
| AbbVie(2 entities) | 7 | $100 |
| Bayer | 4 | $82 |
| Exact Sciences | 2 | $46 |
| Mayne Pharma Commercial LLC | 5 | $41 |
| Merck | 1 | $38 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Pfizer | 2 | $30 |
| Exeltis, USA Inc. | 2 | $29 |
| Avion Pharmaceuticals | 2 | $28 |
| Alydia Health | 2 | $24 |
| Organon | 1 | $17 |
| Coopersurgical, Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Lupin Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$8,970 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 22 | $2,970 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Parsippany
- Craig BissingerParsippany$10K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.